ICU vs TCMD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

ICU

60.7
AI Score
VS
ICU Wins

TCMD

55.2
AI Score

Investment Advisor Scores

ICU

61score
Recommendation
STRONG BUY

TCMD

55score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric ICU TCMD Winner
Forward P/E 0 19.1205 Tie
PEG Ratio 0 17.792 Tie
Revenue Growth 82.0% 8.6% ICU
Earnings Growth 0.0% 144.1% TCMD
Tradestie Score 60.7/100 55.2/100 ICU
Profit Margin 0.0% 7.1% TCMD
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY BUY ICU

Relative Price Performance (Last 90 Days)

ICU 1M: -9.8% · 3M: +11.0% TCMD 1M: -8.6% · 3M: -15.0%

Current Technical Phase

ICU

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.7%), weak momentum, RSI 43

RSI (14): 43.0 · Price: $3.03

TCMD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.7%), weak momentum, RSI 36

RSI (14): 36.2 · Price: $22.40

Fundamentals Snapshot

Metric ICU TCMD
Market Cap
Forward P/E -1.3 15.4
Trailing P/E 20.9
Revenue (TTM)
Revenue Growth 0.8% 0.1%
Gross Margin 0.9% 0.8%
Operating Margin -6.2% 0.1%
EPS -1.89 1.07
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ICU is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.